May 30, 2019 Journal article Open Access

Tesfaye Aychew Legesse; Melese Abate Reta

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Adherence, ART, HIV/AIDS, Associated factors, Hara Town, Ethiopia</subfield>
  </datafield>
  <controlfield tag="005">20250714141349.0</controlfield>
  <controlfield tag="001">8651</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="0">(orcid)0000-0003-1301-4746</subfield>
    <subfield code="a">Melese Abate Reta</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">256645</subfield>
    <subfield code="z">md5:6476d35ec66bf07718d273cfc34edf92</subfield>
    <subfield code="u">https://zenodo.org/record/8651/files/EJHS2903-0299.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-05-30</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:8651</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Tesfaye Aychew Legesse</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Adherence to Antiretroviral Therapy and Associated Factors among People Living with HIV/AIDS in Hara Town and Its Surroundings, North-Eastern Ethiopia</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by-nc/4.0/</subfield>
    <subfield code="a">Creative Commons Attribution-NonCommercial</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;&lt;strong&gt;ABSTRACT&lt;br&gt;
BACKGROUND:&lt;/strong&gt; Adherence is the most important factor in&amp;nbsp;determining Antiretroviral Therapy (ART) treatment success and&amp;nbsp;long-term viral suppression. Nonadherence to ART led to the&amp;nbsp;human Immunodeficiency Virus (HIV) related morbidity and&amp;nbsp;mortality. Moreover, it intensifies the risk of the emerging drug-resistant&amp;nbsp;HIV strains. This study aimed to assess the level of ART&amp;nbsp;adherence and to identify its predictive associated factors among&amp;nbsp;people living with HIV/AIDS in Hara Town and its surroundings,&amp;nbsp;North-Eastern Ethiopia.&lt;br&gt;
&lt;strong&gt;METHODS: &lt;/strong&gt;An institutional facility-based cross-sectional study&amp;nbsp;was conducted from April to May 2017. A total of 454 individuals&amp;nbsp;were on ART follow-up in the selected ART clinic, and only 418&amp;nbsp;patients were recruited. Bivariate and multivariate logistic&amp;nbsp;regression analyses were carried out to identify associated factors.&amp;nbsp;Odds ratio and 95% Confidence Interval (CI) were calculated to&amp;nbsp;determine the level of significance.&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;RESULTS: &lt;/strong&gt;The level of ART adherence in the study setting was 300 (71.8%). Participants who had not disclosed their HIV status to&lt;br&gt;
their families were 88% less likely to adhere to their ART&amp;nbsp;medication than those who had disclosed their HIV status (Odds&lt;br&gt;
ratio (OR): 0.12, 95%CI:0.05-0.58; p&amp;lt;0.001). On the other hand,&amp;nbsp;participants who had not encountered drug side effects were&lt;br&gt;
2.69 times more likely to adhere to their ART medication than&amp;nbsp;those who had ever encountered drug side effects (OR: 2.69,&lt;br&gt;
95%CI:1.27-5.05; p&amp;lt;0.001).&lt;br&gt;
&lt;strong&gt;CONCLUSION: &lt;/strong&gt;A very low level of ART adherence was shown in&amp;nbsp;the study population. It was below the recommended good&amp;nbsp;adherence standard. Therefore, patients should get adequate and&amp;nbsp;comprehensive ART adherence counselling before initiation of ART&amp;nbsp;treatment and during the follow-up time.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">pmid</subfield>
    <subfield code="i">isPublishedIn</subfield>
    <subfield code="a">31447498</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.4314/ejhs.v29i3.2</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>